These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20190188)

  • 1. Uncertainty and patient heterogeneity in medical decision models.
    Groot Koerkamp B; Weinstein MC; Stijnen T; Heijenbrok-Kal MH; Hunink MG
    Med Decis Making; 2010; 30(2):194-205. PubMed ID: 20190188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined analysis of uncertainty and patient heterogeneity in medical decision models.
    Groot Koerkamp B; Stijnen T; Weinstein MC; Hunink MG
    Med Decis Making; 2011; 31(4):650-61. PubMed ID: 20974904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
    Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
    Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decision analysis in radiology using Markov models].
    Golder W
    Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculating partial expected value of perfect information via Monte Carlo sampling algorithms.
    Brennan A; Kharroubi S; O'hagan A; Chilcott J
    Med Decis Making; 2007; 27(4):448-70. PubMed ID: 17761960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining the cost of reducing uncertainty with the selection of risk assessment models for remediation decision of site contamination.
    Chen YC; Ma HW
    J Hazard Mater; 2007 Mar; 141(1):17-26. PubMed ID: 16926066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation sample sizes for Monte Carlo partial EVPI calculations.
    Oakley JE; Brennan A; Tappenden P; Chilcott J
    J Health Econ; 2010 May; 29(3):468-77. PubMed ID: 20378190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision analysis and Markov modeling in urology.
    Hsieh MH; Meng MV
    J Urol; 2007 Nov; 178(5):1867-74. PubMed ID: 17868735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis.
    Stevenson MD; Oakley J; Chilcott JB
    Med Decis Making; 2004; 24(1):89-100. PubMed ID: 15005958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of the determination of autoantibodies against cyclic citrullinated peptide in the early diagnosis of rheumatoid arthritis.
    Konnopka A; Conrad K; Baerwald C; König HH
    Ann Rheum Dis; 2008 Oct; 67(10):1399-405. PubMed ID: 18192304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to account for uncertainty due to measurement errors in an uncertainty analysis using Monte Carlo simulation.
    Hofer E
    Health Phys; 2008 Sep; 95(3):277-90. PubMed ID: 18695409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A primer on use of decision analysis methodology in hand surgery.
    Chen NC; Shauver MJ; Chung KC
    J Hand Surg Am; 2009; 34(6):983-90. PubMed ID: 19481363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
    Hazen GB; Huang M
    Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
    Spiegelhalter DJ; Best NG
    Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
    Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
    Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA.
    O'Hagan A; Stevenson M; Madan J
    Health Econ; 2007 Oct; 16(10):1009-23. PubMed ID: 17173339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Anton SF; Revicki DA
    Psychopharmacol Bull; 1995; 31(2):249-58. PubMed ID: 7491376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations.
    Trikalinos TA; Siebert U; Lau J
    Med Decis Making; 2009; 29(5):E22-9. PubMed ID: 19734441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.